Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
Tartary Buckwheat Flavonoids Improve Colon Lesions and Modulate Gut Microbiota Composition in Diabetic Mice. β
Go to Publication β
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2022 Issue Pages: 4524444 Pub: 2022 Epub: 2022 Aug 16 Authors Cheng W , Cai C , Kreft I , Turnšek TL , Zu M , Hu Y , Zhou M , Liao Z , |
|
Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993501 Pub: 2022 Epub: 2022 Nov 14 Authors Zhang D , Xu Y , Chen H , Wang D , Geng Z , Chen Y , Chen Y , Xiong D , Yang R , Liu X , Zhang Y , Xiang P , Ma L , Liu J , |
|
Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993501 Pub: 2022 Epub: 2022 Nov 14 Authors Zhang D , Xu Y , Chen H , Wang D , Geng Z , Chen Y , Chen Y , Xiong D , Yang R , Liu X , Zhang Y , Xiang P , Ma L , Liu J , |
|
Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993501 Pub: 2022 Epub: 2022 Nov 14 Authors Zhang D , Xu Y , Chen H , Wang D , Geng Z , Chen Y , Chen Y , Xiong D , Yang R , Liu X , Zhang Y , Xiang P , Ma L , Liu J , |
|
Fagopyrum dibotrys extract alleviates hepatic steatosis and insulin resistance, and alters autophagy and gut microbiota diversity in mouse models of high-fat diet-induced non-alcoholic fatty liver disease. β
Go to Publication β
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 993501 Pub: 2022 Epub: 2022 Nov 14 Authors Zhang D , Xu Y , Chen H , Wang D , Geng Z , Chen Y , Chen Y , Xiong D , Yang R , Liu X , Zhang Y , Xiang P , Ma L , Liu J , |
|
Effects of extracted oil of fermented Tartary buckwheat on lipid-lowering, inflammation modulation, and gut microbial regulation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10814-10828 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Yang X , Zhu A , Li X , He S , Zhu Y , Anyan W , Qin L , Zeng H , |
|
Tartary Buckwheat (Fagopyrum tataricum) Ameliorates Lipid Metabolism Disorders and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 19 Pages: Pub: 2022 Sep 29 Epub: 2022 Sep 29 Authors Li A , Wang J , Wang Y , Zhang B , Chen Z , Zhu J , Wang X , Wang S , |
|
Growth performance, lipid metabolism, and systemic immunity of weaned piglets were altered by buckwheat protein through the modulation of gut microbiota. β
Go to Publication β
Molecular genetics and genomics : MGG (Mol Genet Genomics ) Vol: 299 Issue 1 Pages: 15 Pub: 2024 Feb 27 Epub: 2024 Feb 27 Authors Tu W , Nie W , Yao X , Zhang J , Zhang H , Di D , Li Z , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]